Characterising and targeting the IL-17/IL-23 inflammatory axis in ankylosing spondylitis and inflammatory bowel disease (360G-Wellcome-102288_Z_13_Z)
Compelling evidence implicates the IL-17/IL-23 inflammatory axis in ankylosing spondylitis (AS),rheumatoid arthritis (RA), as well as inflammatory bowel disease (IBD), with early clinical trials targeting this pathway in AS showing promising results. Central to this axis are innate and adaptive immune cells expressing the ROR-gammat transcription factor. Murine studies suggest that small molecules can directly inhibit ROR-gammat. However, It remains unclear which subset of patients or which diseases may be most responsive to blockade of this pathway, or which components of the axis are most critical. Firstly, I will characterize the IL-17/IL-23 axis in the blood and tissue of patients with AS and RA and compare these responses in collaboration with colleagues looking at IBD. Secondly I will compare the effects of ROR-gammat inhibitors with neutralizing antibodies on different classes of ROR- gammat-expressing cells including CD4+, CD8+, CD4-CD8-CD3+ and innate lymphoid cells. The key goals are to identify: 1) The cellular components of this inflammatory axis in the disease setting 2) The effects of inhibitors on the different cell types involved 3) Potential biomarkers for targeting therapy These studies would form the foundation for proof of concept clinical trials with therapeutic implications across the spectrum of inflammatory diseases.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 233952 |
Applicant Surname | Al-Mossawi |
Approval Committee | PhD Studentships |
Award Date | 2013-06-24T00:00:00+00:00 |
Financial Year | 2012/13 |
Grant Programme: Title | PhD Training Fellowship for Clinicians |
Internal ID | 102288/Z/13/Z |
Lead Applicant | Dr Mohammad Al-Mossawi |
Partnership Value | 233952 |
Planned Dates: End Date | 2016-07-31T00:00:00+00:00 |
Planned Dates: Start Date | 2013-08-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | South East |
Sponsor(s) | Prof Rajesh Thakker |